myocardi
ischemiareperfus
ir
injuri
lead
caus
morbid
mortal
cardiac
surgeri
heart
infarct
sharma
et
al
accumul
evid
vivo
vitro
studi
strongli
suggest
apoptosi
one
major
mechan
cardiomyocyt
injuri
follow
hypoxia
lam
et
al
reactiv
oxygen
speci
ro
overproduct
play
crucial
role
myocyt
apoptosi
ir
injuri
takano
et
al
hypoxiareoxygen
hr
initi
mitochondri
apoptot
pathway
induc
massiv
ro
product
loss
mitochondri
membran
potenti
stimul
cytochrom
c
releas
activ
subsequ
activ
ultim
result
apoptosi
ryter
et
al
henc
inhibit
intracellular
ro
level
prevent
cardiomyocyt
apoptosi
effect
strategi
amelior
myocardi
ir
injuri
myricitrin
natur
occur
flavonoid
glycosid
belong
flavonol
subgroup
abundantli
distribut
fruit
branch
bark
leav
myrica
rubra
plant
myrica
esculenta
ampelopsi
grossedentata
nymphaea
lotu
chrysobalanu
icaco
huang
et
al
shown
myricitrin
possess
consider
antioxid
activ
sun
et
al
domitrov
et
al
antinocicept
action
meotti
et
al
antiinflammatori
activ
shimosaki
et
al
antifibrot
activ
geng
et
al
previous
demonstr
myricitrin
abl
protect
endothelia
cell
rosinduc
apoptosi
prevent
plaqu
format
earli
stage
atherosclerot
mous
model
sun
et
al
qin
et
al
also
report
myricitrin
inhibit
high
glucoseinduc
cardiomyocyt
apoptosi
prevent
diabet
cardiomyopathi
zhang
et
al
experi
indic
myricitrin
use
prevent
treatment
cardiovascular
diseas
howev
report
effect
mechan
myricitrin
cardiomyocyt
apoptosi
follow
ir
therefor
object
present
studi
investig
effect
myricitrin
cardiomyocyt
subject
hr
simul
ir
underli
molecular
target
myricitrin
ir
injuri
also
elucid
use
bioinformat
approach
myricitrin
provid
institut
medicin
plant
develop
beij
china
sun
et
al
cell
cultur
product
purchas
gibco
brl
grand
island
ny
unit
state
fluoresc
dye
purchas
sigmaaldrich
st
loui
mo
unit
state
annexin
vpropidium
iodid
pi
apoptosi
detect
kit
obtain
invitrogen
corpor
eugen
unit
state
fluorometr
assay
kit
acquir
biovis
milpita
ca
unit
state
primari
antibodi
bax
obtain
santa
cruz
biotechnolog
inc
santa
cruz
ca
unit
state
primari
antibodi
akt
pakt
purchas
abcam
cambridg
unit
kingdom
horseradish
peroxidas
hrp
conjug
secondari
antibodi
obtain
cw
biotech
beij
china
cardiomyocyt
line
obtain
chines
academi
scienc
cell
bank
shanghai
china
cultur
previous
describ
wang
et
al
briefli
cell
cultur
high
glucos
dmem
supplement
vv
fetal
bovin
serum
penicillinstreptomycin
vv
mm
lglutamin
cell
maintain
rel
humid
incub
contain
hr
procedur
modifi
previou
studi
sun
et
al
wang
et
al
cardiomyocyt
cultur
anaerob
glove
box
coy
laboratori
unit
state
hypoxia
h
subsequ
cell
remov
anaerob
glove
box
medium
replac
high
glucos
medium
maintain
h
incub
mimic
reperfus
experi
cell
plate
appropri
densiti
accord
experiment
design
grown
h
reach
confluenc
prior
experiment
cultur
cardiomyocyt
randomli
divid
differ
group
control
con
group
cardiomyocyt
incub
normox
condit
equival
durat
high
glucos
dmem
hr
group
conduct
describ
preced
section
myricitrintr
group
hrmyr
cardiomyocyt
pretreat
myricitrin
h
prior
hr
inhibitortr
group
process
hrmyr
group
cell
preincub
h
remov
medium
treat
myricitrin
appropri
concentr
select
inhibitor
determin
basi
data
found
literatur
wu
et
al
preliminari
experi
supplementari
figur
cell
viabil
determin
use
tetrazolium
mtt
assay
previous
describ
sun
et
al
briefli
cell
plate
onto
plate
densiti
cellswel
design
treatment
mtt
mgml
ad
well
incub
h
medium
subsequ
remov
formazan
crystal
dissolv
dimethyl
sulfoxid
dmso
absorb
read
nm
use
micropl
reader
tecan
infinit
austria
supernat
cell
collect
differ
treatment
measur
lactat
dehydrogenas
ldh
catalas
cat
glutathion
peroxidas
gshpx
malondialdehyd
mda
level
well
superoxid
dismutas
sod
activ
use
correspond
detect
kit
nanj
jiancheng
bioengin
institut
nanj
china
accord
manufactur
instruct
effect
myricitrin
intracellular
ro
level
monitor
use
total
ro
detect
kit
accord
manufactur
instruct
enzo
life
scienc
inc
farmingdal
ny
unit
state
briefli
cell
precondit
myricitrin
h
expos
h
hypoxia
follow
h
reoxygen
treatment
cell
harvest
place
roundbottom
polystyren
tube
wash
wash
buffer
subsequ
cell
centrifug
min
g
room
temperatur
supernat
discard
cell
resuspend
ro
detect
solut
stain
dark
min
analyz
use
flow
cytometri
sun
et
al
use
iodid
sigmaaldrich
st
loui
mo
unit
state
analyz
chang
mitochondri
transmembran
potenti
previous
describ
sun
et
al
cell
preincub
myricitrin
follow
hr
procedur
treatment
cell
incub
min
dark
wash
twice
phosphatebuff
salin
pb
cell
label
analyz
bd
facscalibur
flow
cytometri
use
nm
excit
green
nm
orang
nm
emiss
wavelength
cellquest
softwar
posit
rate
express
percentag
redgreen
fluoresc
intens
rel
control
group
percentag
earli
apoptosi
necrosi
measur
use
annexin
vfitcpi
apoptosi
kit
flow
cytometri
accord
manufactur
instruct
invitrogen
treatment
cell
harvest
wash
twice
cold
pb
subsequ
incub
fitcannexin
v
pi
work
solut
cell
suspens
min
dark
room
temperatur
cellular
fluoresc
measur
flow
cytometri
analysi
fac
caliburtm
bd
bioscienc
san
jose
ca
unit
state
activ
sun
et
al
activ
sun
et
al
measur
use
correspond
fluorometr
assay
kit
biovis
ca
unit
state
accord
manufactur
instruct
assess
activ
cell
resuspend
lysi
buffer
kept
ice
min
ml
reaction
buffer
contain
mm
dithiothreitol
ad
sampl
ml
mm
substrat
lehdafc
h
sampl
determin
use
micropl
reader
tecan
infinit
austria
excit
wavelength
nm
emiss
wavelength
nm
analysi
activ
cell
harvest
incub
substrat
fitcdevdfmk
h
centrifug
rpm
min
supern
remov
wash
twice
cold
pb
cell
resuspend
wash
buffer
transfer
cell
suspens
well
black
microtit
plate
fluoresc
intens
detect
use
micropl
reader
excit
wavelength
nm
emiss
wavelength
nm
treatment
cell
harvest
wash
pb
lyse
cell
lysi
buffer
contain
phenylmethylsulfonyl
fluorid
lysat
prepar
western
blot
analysi
perform
previous
describ
sun
et
al
immunoblot
develop
use
electrochemiluminesc
ecl
kit
molecular
target
myricitrin
predict
use
discoveri
studio
ds
biovia
softwar
inc
san
diego
ca
unit
state
molecular
structur
myricitrin
submit
mont
carlo
base
conform
analysi
discoveri
studio
fast
algorithm
allow
maxim
conform
less
kcalmol
energi
minimum
pharmadb
pharmacophor
databas
implement
ds
profil
pharmadb
pharmacophor
model
shape
bind
pocket
select
virtual
screen
use
default
set
ligand
profil
modul
ds
rigid
mode
use
molecular
map
algorithm
screen
conduct
use
default
set
minim
interfeatur
distanc
input
paramet
job
run
result
sheet
return
indic
model
hit
well
myricitrin
map
model
fit
valu
respect
higher
fit
valu
repres
better
fit
rolling
et
al
yi
et
al
result
express
mean
standard
deviat
comparison
perform
use
student
ttest
oneway
anova
follow
tukey
multipl
comparison
test
use
prism
softwar
statist
signific
set
p
data
result
least
three
independ
experi
protect
effect
myricitrin
hrinduc
cell
death
detect
use
mtt
assay
shown
figur
supplementari
figur
myricitrin
pretreat
exhibit
strong
protect
effect
pretreat
h
surviv
rate
increas
hr
treatment
alon
treatment
myricitrin
respect
ldh
secret
cell
plasma
membran
disrupt
use
indic
cell
injuri
shown
figur
myricitrin
pretreat
decreas
ldh
level
cultur
medium
concentrationdepend
manner
p
p
effect
consist
protect
effect
cell
viabil
assess
use
mtt
assay
oxid
stress
long
associ
heart
injuri
respons
ir
kalogeri
et
al
membran
lipid
oxid
one
primari
event
oxid
damag
assess
accord
degrad
product
mda
rodrigo
et
al
shown
figur
hr
group
show
signific
increas
intracellular
mda
level
wherea
signific
reduct
level
mda
observ
myricitrin
pretreat
group
compar
hr
group
confirm
antioxid
effect
myricitrin
activ
endogen
antioxid
enzym
sod
cat
gshpx
detect
myricitrin
pretreat
significantli
enhanc
sod
cat
gshpx
activ
compar
hr
group
figur
p
p
base
flow
cytometri
stain
examin
effect
myricitrin
treatment
intracellular
ro
level
shown
figur
f
hr
significantli
increas
ro
level
nearli
threefold
compar
control
demonstr
shift
fluoresc
left
right
howev
myricitrin
pretreat
partial
block
effect
suggest
myricitrin
pretreat
decreas
ro
level
oxid
stressinduc
apoptosi
associ
loss
mitochondri
membran
potenti
earli
marker
apoptosi
sun
et
al
mitochondri
depolar
indic
decreas
redgreen
fluoresc
intens
ratio
stain
hr
group
exhibit
increas
green
fluoresc
intens
indic
dissip
figur
b
pretreat
myricitrin
attenu
depolar
indic
increas
red
fluoresc
p
confirm
antiapoptot
effect
myricitrin
quantit
analysi
fitcannexin
vpi
stain
use
flow
cytometri
percentag
apoptot
cell
hr
group
significantli
increas
compar
control
group
figur
contrast
pretreat
myricitrin
dramat
decreas
ratio
apoptot
cell
caspas
activ
also
use
assess
level
apoptosi
zhuang
et
al
shown
figur
b
activ
activ
level
markedli
increas
hr
treatment
myricitrin
pretreat
significantli
inhibit
effect
p
understand
mechan
myricitrin
treatment
regul
cell
apoptosi
measur
effect
myricitrin
express
apoptosisrel
protein
express
use
western
blot
analysi
shown
figur
hr
group
show
decreas
express
antiapoptot
protein
increas
express
proapoptot
protein
bax
pretreat
myricitrin
increas
express
ratio
compar
hr
group
vs
respect
molecular
target
myricitrin
predict
use
discoveri
studio
softwar
figur
rank
accord
fit
score
descend
order
top
diseaserel
target
shown
tabl
among
target
focus
heat
shock
protein
critic
target
protect
myocardium
ir
injuri
accumul
evid
shown
upregul
express
protect
cardiomyocyt
irinduc
damag
wu
et
al
thu
detect
express
level
cardiomyocyt
shown
figur
cell
treat
myricitrin
h
signific
increas
express
level
observ
next
detect
effect
myricitrin
express
level
hrtreat
cardiomyocyt
figur
show
myricitrin
treatment
significantli
inhibit
downregul
hrinduc
express
determin
whether
elev
express
respons
cell
protect
effect
myricitrin
select
inhibitor
util
shown
figur
inhibitor
revers
protect
hr
injuri
decreas
cell
viabil
figur
phosphoryl
level
prosurviv
protein
akt
figur
mitochondri
membran
potenti
figur
addit
presenc
decreas
mitochondri
ro
level
induc
myricitrin
also
abolish
figur
f
result
suggest
involv
protect
effect
myricitrin
hr
injuri
cell
oxid
stress
implic
injuri
associ
myocardi
ischemiareperfus
induc
ro
product
kalogeri
et
al
flavonoid
contain
catechol
group
describ
scaveng
mimic
sod
play
import
role
oxid
stress
meotti
et
al
myricitrin
belong
flavonol
subgroup
reportedli
possess
effect
antioxid
activ
domitrov
et
al
stronger
free
radic
scaveng
activ
flavonol
rhamnosid
quercetin
wu
et
al
similarli
result
present
studi
clearli
show
ro
product
well
preserv
result
myricitrin
pretreat
hr
effect
accompani
significantli
elev
activ
sod
gshpx
cat
decreas
level
mda
suggest
cardioprotect
effect
myricitrin
ir
larg
associ
antioxid
capac
addit
produc
oxid
injuri
cardiomyocyt
apoptosi
also
one
major
contributor
develop
myocardi
ir
injuri
van
empel
et
al
hypoxia
excess
ro
alter
mitochondri
structur
trigger
mitochondri
depolar
well
dissip
sinha
et
al
disrupt
induc
releas
proapoptot
molecul
mitochondria
subsequ
activ
caspas
result
apoptosi
sinha
et
al
present
studi
result
indic
myricitrin
maintain
mitochondri
membran
potenti
decreas
activ
activ
reduc
apoptosi
rate
cardiomyocyt
hr
activ
induc
proapoptot
bax
inhibit
antiapoptot
kaushal
et
al
western
blot
analysi
show
myricitrin
increas
ratio
compar
hr
group
data
demonstr
myricitrin
effect
inhibit
hrinduc
apoptosi
provid
evid
support
antiapoptot
role
qin
et
al
zhang
et
al
myricitrin
interact
protein
kinas
nitric
oxid
synthas
no
pereira
et
al
schwank
et
al
qin
et
al
addit
previou
studi
demonstr
myricitrin
potent
inhibit
calcium
transport
like
interact
phenol
group
flavonoid
transport
protein
thiyagarajah
et
meotti
et
al
present
studi
investig
potenti
target
may
signific
relationship
pharmacolog
effect
myricitrin
use
bioinformat
approach
among
target
myricitrin
main
protein
involv
ir
injuri
abund
chaperon
regul
cell
signal
function
mani
protein
bind
refer
client
protein
wang
et
al
accord
previou
studi
direct
effector
enabl
activ
prosurviv
pathway
barksdal
bijur
recent
year
studi
shown
mediat
mitochondri
import
buda
et
al
zhong
et
al
play
integr
role
endotheli
no
signal
amour
et
al
therebi
effici
protect
myocardium
ir
injuri
kupatt
et
al
zhu
et
al
furthermor
facilit
inhibitori
effect
sr
calcium
uptak
protect
ir
injuri
lam
et
al
thu
specul
one
target
myricitrin
reliev
hr
injuri
cardiomyocyt
next
investig
role
cardioprotect
myricitrin
hr
injuri
expect
myricitrin
pretreat
obvious
block
inhibitori
effect
hr
express
act
upstream
regul
serinethreonin
protein
kinas
akt
surviv
pathway
cellular
stress
barksdal
bijur
previous
show
myricitrin
mediat
cardiovascular
protect
activ
akt
signal
pathway
qin
et
al
zhang
et
al
present
studi
addit
inhibitor
substanti
decreas
akt
phosphoryl
induc
myricitrin
therebi
attenu
prosurviv
effect
pathway
addit
inhibit
markedli
abolish
myricitrininduc
cardioprotect
hr
injuri
shown
increas
overproduct
mitochondri
ro
loss
mmp
find
consist
recent
report
antiapoptot
cardiomyocyt
antioxid
preserv
mitochondri
function
stress
condit
wu
et
al
base
result
suggest
involv
cardioprotect
effect
myricitrin
interact
myricitrin
may
promot
antiapoptot
signal
pathway
cardiomyocyt
hr
injuri
result
present
studi
indic
myricitrin
dietari
flavonoid
compound
exert
profound
cardioprotect
effect
hr
injuri
cardiomyocyt
suppress
oxid
stress
apoptosi
contribut
myricitrininduc
cardioprotect
effect
least
part
pathway
although
experi
requir
elucid
precis
mechan
underli
protect
associ
varieti
signal
molecul
result
suggest
myricitrin
may
promis
therapeut
candid
treatment
myocardi
ir
injuri
gb
jxi
xb
conduct
studi
mw
design
detail
experi
perform
studi
collect
analyz
data
yyd
yt
pl
xsl
took
part
cell
experi
studi
author
comment
studi
approv
final
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
